GTx Inc. (GTXI +5.7%) regains some lost traction from yesterday after the company reported that...

|By:, SA News Editor

GTx Inc. (GTXI +5.7%) regains some lost traction from yesterday after the company reported that its drug, enobosarm, which is indicated for the prevention and treatment of muscle wasting in patients with non-small cell lung cancer, has been given a Fast Track designation by the FDA.